These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases]. Schindewolf M; Magnani HN; Lindhoff-Last E Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171 [TBL] [Abstract][Full Text] [Related]
36. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy. Davenport A Am J Kidney Dis; 1998 Oct; 32(4):E3. PubMed ID: 10074589 [TBL] [Abstract][Full Text] [Related]
37. HIT/HITT and alternative anticoagulation: current concepts. Lakshmanan S; Saha B; Rittoo D Br J Anaesth; 2003 Sep; 91(3):445; author reply 445-6. PubMed ID: 12966934 [No Abstract] [Full Text] [Related]
38. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia. Tardy-Poncet B; Tardy B; Reynaud J; Mahul P; Mismetti P; Mazet E; Guyotat D Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558 [TBL] [Abstract][Full Text] [Related]
39. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia. Jackson MR; Danby CA; Alving BM Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582 [TBL] [Abstract][Full Text] [Related]
40. Delayed cutaneous reaction to unfractionated heparin, low molecular weight heparin and danaparoid. Sivakumaran M; Ghosh K; Munks R; Gelsthorpe K; Tan L; Wood JK Br J Haematol; 1994 Apr; 86(4):893-4. PubMed ID: 7802799 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]